$28.46
+0.08 (+0.28%)
Open$29.27
Previous Close$28.38
Day High$29.91
Day Low$28.01
52W High$44.60
52W Low$13.50
Volume—
Avg Volume506.0K
Market Cap1.81B
P/E Ratio—
EPS$-8.97
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+3.7% upside
Current
$28.46
$28.46
Target
$29.51
$29.51
$22.12
$29.51 avg
$35.27
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 14.26M | 140.52M | 130.81M |
| Net Income | -538,514,896 | -116,113 | -126,311 |
| Profit Margin | -3,777.4% | -0.1% | -0.1% |
| EBITDA | -546,020,485 | -178,287 | -168,053 |
| Free Cash Flow | — | -139,366 | -118,293 |
| Rev Growth | — | -3.7% | +16.0% |
| Debt/Equity | 0.32 | 0.89 | 0.92 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |